Takemi Program in International Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Department of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
JAMA Netw Open. 2023 Jun 1;6(6):e2319583. doi: 10.1001/jamanetworkopen.2023.19583.
The COVID-19 pandemic may have played a role in the deterioration of access to medical care for ambulatory care-sensitive conditions (ACSCs).
To ascertain whether the number of in-hospital deaths and in-hospital mortality rate associated with ACSC changed after the declaration of the COVID-19 national state of emergency in Japan.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study used a difference-in-differences design to compare outcomes for ACSC in the period before (January 1, 2015, to December 31, 2019) vs the period after (January 1, 2020, to December 31, 2020) Japan declared a national state of emergency for the COVID-19 pandemic. Analyses used discharge summary data from 242 acute care hospitals across Japan. The sample comprised unscheduled hospitalizations of patients with ACSC during the study period (January 1, 2015, to December 31, 2020). Data analyses were performed between August 16 and December 7, 2022.
The declaration of the COVID-19 national state of emergency announced by the Japanese government in April 2020 was considered to be an exogenous shock.
Primary outcomes were the ACSC-associated number of in-hospital deaths, number of hospitalizations, and in-hospital mortality rate.
A total of 28 321 ACSC-related hospitalizations were observed involving 15 318 males (54.1%), with a median (IQR) age of 76 (58-85) years. The number of in-hospital deaths was 2117 (7.5%). The number of hospitalizations decreased overall (incidence rate ratio [IRR], 0.84; 95% CI, 0.75-0.94), for chronic conditions (IRR, 0.84; 95% CI, 0.77-0.92), and for vaccine-preventable conditions (IRR, 0.58; 95% CI, 0.44-0.76). However, in-hospital deaths (IRR, 1.66; 95% CI, 1.15-2.39) and in-hospital deaths within 24 hours of hospital arrival (IRR, 7.27 × 106; 95% CI, 1.83 × 106 to 2.89 × 107) increased for acute conditions. The in-hospital mortality rate increased for acute conditions (IRR, 1.71; 95% CI, 1.16-2.54), and the 24-hour in-hospital mortality rates also increased overall (IRR, 1.87; 95% CI, 1.19-2.96), for acute conditions (IRR, 2.15 × 106; 95% CI, 5.25 × 105 to 8.79 × 106), and for vaccine-preventable conditions (IRR, 4.64; 95% CI, 1.28-16.77).
This cohort study found that in Japan, the number of in-hospital deaths increased after the declaration of the COVID-19 national state of emergency in 2020, particularly for acute ACSC and deaths within 24 hours of hospital admission. This finding suggests that access to good-quality primary care and inpatient care for patients with acute ACSC may have been compromised during the pandemic.
重要性:新冠疫情大流行可能影响到门诊医疗敏感条件(ACSC)的医疗服务获取。
目的:确定在日本宣布新冠疫情全国紧急状态后,与 ACSC 相关的住院死亡人数和住院死亡率是否发生变化。
设计、地点和参与者:本队列研究采用差异中的差异设计,比较了日本宣布新冠疫情全国紧急状态前后(2020 年 1 月 1 日至 12 月 31 日和 2020 年 1 月 1 日至 12 月 31 日)期间 ACSC 的结果。分析使用了来自日本 242 家急性护理医院的出院总结数据。样本包括研究期间 ACSC 的非计划性住院患者(2015 年 1 月 1 日至 2020 年 12 月 31 日)。数据分析于 2022 年 8 月 16 日至 12 月 7 日进行。
暴露:日本政府于 2020 年 4 月宣布的新冠疫情全国紧急状态被认为是一种外生冲击。
主要结局和测量:主要结局是与 ACSC 相关的住院死亡人数、住院人数和住院死亡率。
结果:共观察到 28321 例 ACSC 相关住院治疗,其中 15318 例为男性(54.1%),中位(IQR)年龄为 76(58-85)岁。死亡人数为 2117 人(7.5%)。总的来说,住院人数减少(发病率比[IRR],0.84;95%CI,0.75-0.94),慢性病(IRR,0.84;95%CI,0.77-0.92)和可预防疫苗的疾病(IRR,0.58;95%CI,0.44-0.76)。然而,急性病的住院死亡人数(IRR,1.66;95%CI,1.15-2.39)和住院后 24 小时内死亡人数(IRR,7.27×106;95%CI,1.83×106 至 2.89×107)增加。急性病的住院死亡率(IRR,1.71;95%CI,1.16-2.54)和 24 小时住院死亡率也总体增加(IRR,1.87;95%CI,1.19-2.96),急性病(IRR,2.15×106;95%CI,5.25×105 至 8.79×106)和可预防疫苗的疾病(IRR,4.64;95%CI,1.28-16.77)。
结论和相关性:本队列研究发现,2020 年日本宣布新冠疫情全国紧急状态后,住院死亡人数增加,特别是急性 ACSC 和住院后 24 小时内死亡人数增加。这一发现表明,在大流行期间,急性 ACSC 患者获得高质量初级保健和住院治疗的机会可能受到了影响。